Terra Bioforge is a synthetic biology company that leverages proprietary genetic engineering, genomics, and AI-driven platforms to discover and manufacture microbial natural products for the pharmaceutical, agriculture, and biotech industries.
Terra Bioforge is a synthetic biology company that specializes in microbial strain engineering for the discovery and production of valuable natural products. The company utilizes a proprietary platform that integrates genomics, metabolomics, AI-driven metabolite analysis, and data science to reprogram biosynthetic pathways. Their core technologies include MycoDrive, a genome engineering platform for filamentous fungi, and a Metabologenomics approach that maps microbial molecules to their specific genetic recipes. By offering custom genetic engineering services for bacterial and fungal strains—such as Bacillus, Paenibacillus, and Streptomyces—the company enables the creation of efficient microbial factories for various industrial applications.
These capabilities are designed to help pharmaceutical and agtech partners shorten R&D timelines, increase fermentation efficiency, and reduce production costs for complex chemistries. The company supports projects across human health, animal health, and agriculture, including tasks such as optimizing nutrient utilization, stable fluorescent labeling, and the secretion of bioactive peptides or enzymes. By enabling the scalable production of natural compounds, Terra Bioforge assists customers in bringing products to market faster and more cost-effectively, addressing significant production challenges in the biotechnology and life sciences industries.